^
    CANCER:
    Small Intestinal Carcinoma
    PTEN mutation + MSI-H/dMMR
    Small Intestinal Carcinoma
    PD1 inhibitor
    Resistant
    :
    C3
    Clin Cancer Res - 1wk
    dMMR/MSI-H + TMB-L
    Small Intestinal Carcinoma
    PD1 inhibitor
    Resistant
    :
    C3
    Clin Cancer Res - 1wk
    NTRK3 fusion
    Small Intestinal Carcinoma
    entrectinib
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    gemcitabine + docetaxel
    Sensitive
    :
    A2
    NTRK1 fusion
    Small Intestinal Carcinoma
    entrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Small Intestinal Carcinoma
    entrectinib
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    pembrolizumab
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    gemcitabine + albumin-bound paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    LV5FU2
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    nivolumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    pembrolizumab + ipilimumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Small Intestinal Carcinoma
    nivolumab + ipilimumab
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    FOLFOX
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    CAPOX
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    bevacizumab
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    capecitabine
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    5-fluorouracil
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    irinotecan
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    FOLFIRI
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    albumin-bound paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    docetaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    paclitaxel
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    paclitaxel + gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Small Intestinal Carcinoma
    carboplatin + paclitaxel
    Sensitive
    :
    A2
    NTRK1 fusion
    Small Intestinal Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Small Intestinal Carcinoma
    larotrectinib
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES